Related references
Note: Only part of the references are listed.A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients
V. Liu et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
Rene Alvarez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients
J. Kuypers et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Community-Acquired Respiratory Viral Infections in Lung Transplant Recipients: A Single Season Cohort Study
Jens Gottlieb et al.
TRANSPLANTATION (2009)
Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus
Peter Hopkins et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
John DeVincenzo et al.
ANTIVIRAL RESEARCH (2008)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A single-season prospective study of respiratory viral infections in lung transplant recipients
A. P. Milstone et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation
AR Glanville et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes
C Matranga et al.
CELL (2005)
Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation
TA Rand et al.
CELL (2005)
Activation of the mammalian immune system by siRNAs
JT Marques et al.
NATURE BIOTECHNOLOGY (2005)
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant
D Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus
SM Perkins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Inhibition of respiratory viruses by nasally administered siRNA
V Bitko et al.
NATURE MEDICINE (2005)
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death
AP Khalifah et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Protection against lethal influenza virus challenge by RNA interference in vivo
SM Tompkins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin
LH McCurdy et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2003)
Inhibition of hepatitis B virus in mice by RNA interference
AP McCaffrey et al.
NATURE BIOTECHNOLOGY (2003)
Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria
M Estenne et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2002)
Share Paper
